Zanidatamab in HER2-Positive Metastatic Biliary Tract Cancer: Final Results From HERIZON-BTC-01.

ABSTRACT:

SUBMITTER: Pant S 

PROVIDER: S-EPMC12635922 | biostudies-literature | 2026 Jan

REPOSITORIES: biostudies-literature